BC Cancer Agency-Fraser Valley Centre

Surrey, British Columbia V3V 1Z2

0 studies enrolling now · 5 studies all time

What they study most

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Multiple Myeloma, Non-small Cell Lung Cancer, Ovarian Cancer, Peritoneal Cancer

Studies at this site

• A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2) — Completed
• A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) — Completed
• Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed
• LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy — Completed
• A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) — Completed